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Summary
We have previously demonstrated that primitive progenitors from human bone marrow termed
long term bone marrow culture initiating cells (LTBMC-IC) adhere avidly to irradiated bone
marrow stroma, while more mature clonogenic progenitors fail to do so . In this studywe examine
the interaction between these progenitors and components of the bone marrow stroma. (a) We
demonstrate that both primitive LTBMC-IC and more mature clonogenic progenitors adhere
to intact fibronectin . (b) Primitive LTBMC-IC and multi-lineage CFU-MIX progenitors adhere
to the 33/66 kDCOOH-terminal heparin-binding cell-adhesion promoting fragment offibronectin,
but adhere significantly less to its 75 kD RGDS-dependent cell-binding fragment . In contrast,
more differentiated single-lineage progenitors adhere equally well to the 33/66 kD RGDS
independent and the 75 kD RGDS-dependent cell-adhesion fragments of fibronectin . (c) Both
primitive LTBMC-IC and clonogenic progenitors adhere to the three known cell-attachment
sites in the 33/66 kD cell-adhesion promoting fragment, FN-C/H I, FN-C/H II and CS1 . However,
LTBMC-IC and CFU-MIX progenitors adhere significantly better to FN-C/H lI than to the
flankingFN-C/H I and CS1 cell-attachment sites. In contrast, single-lineage progenitors adhere
equally well to all three cell attachment sites in the 33/66kD cell-adhesion promoting fragment .
(d) Finally, adhesion ofprimitiveLTBMC-IC to intact irradiated stroma can be inhibited partially
by peptide FN-C/H II and almost completely by a combination ofFN-C/H II and peptide FN-
C/H I and CS1 . This study demonstrates that adhesive interactions between primitive hematopoietic
progenitors and the extracellular matrix component fibronectin can occur. Specific changes in
adhesion to the 33/66 kD cell-adhesion promoting fragment and the 75 kD RGDS-dependent
cell-adhesion fragment offibronectin are associated with differentiation ofprimitive multi-lineage
progenitors into committed single-lineage progenitors . Such differences in adhesive interaction
with fibronectin may allow hematopoietic progenitors at various stages ofdifferentiation to interact
with specific supportive loci of the bonemarrow microenvironment . Finally, the ability to block
adhesion of LTBMC-IC to intact irradiated stroma with peptides FN-C/H II, FN-C/H I and
CS1 suggests that receptors responsible for this interaction may be important in the homing
of primitive progenitors to the bone marrow.
T
he role of bone marrow stromal cells and/or extracel-
lular matrix molecules in promoting proliferation and
differentiation of primitive hematopoietic cells has been well
established through the development of long term stromal
based cultures for both myeloid hematopoietic cells (1) and
lymphoid cells (2) . The stromal elements of such cultures
can sustain proliferation of primitive self-renewing hemato-
poietic cells (3, 4) and support differentiation and matura-
tion of primitive progenitor cells into committed progen-
itors and mature blood elements (1, 2, 5-8) . The influences
of stromal elements on the early events which induce primi-
tive, multi-lineage hematopoietic progenitors to proliferate,
differentiate or assume single lineagecommitment are largely
unknown . Bone marrow derived stroma consists of several
cell types (1) and a variety of extra-cellular matrix molecules.
Extracellular matrix components such as fibronectin (9-15),
laminin (16), hemonectin (17, 18), thrombospondin (19), pro-
teoglycans (20, 21) and glycosaminoglycans (22) have been
implicated in the adherence of committed clonogenic pro-
genitors to stroma. Adhesive interactions ofmore primitive
hematopoietic progenitors with stromal elements have been
less well studied .
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marrow (23, 24). Its role in the differentiation and matura-
tion of erythroid and B lymphoid progenitors has been ex-
tensively studied (9-15) . The possible role of fibronectin in
homing of more primitive progenitors from human bone
marrow and their differentiation into committed hematopoi-
etic elements has, however, not yet been examined. Fibronectin
has served as the prototype molecule for studies involving
adhesion of cells with the extracellular matrix. Interaction
of different cell types with fibronectin is important for their
localization into organs (25). Fibronectin may have an in-
structive and permissive role in allowing immature cells to
respond to soluble mediators and other mitogenic signals (26).
Since fibronectin is universally present, specificity and selec-
tivity for the adhesion ofdifferent cell types or the same cells
at different stages of maturation to fibronectin is provided
byboth tissue specific expressionof various forms offibronectin
(25) and differential expression of multiple fibronectin cell
surface receptors (27, 28).
Various domains ofthe fibronectin molecule which interact
with different cell surface receptors have been identified. A
75-120 kD proteolytic fragment in the center ofthe fibronectin
molecule contains the sequence arginyl-glycyl-aspartyl-serine
(RGDS)' (Fig. 1) (29, 30). The txSf1 cell surface integrin
complex(27, 30) is responsible for the interaction of different
cell types with this RGDS-containing fragment offibronectin.
Adhesion to fibronectin can also occur in an RGDS-inde-
pendent fashion via the33/66kD "heparin-binding fragment"
at the COOH-terminal end of the fibronectin molecule
(31-36). Three RGDS-independent cell-adhesion promoting
peptide sequences have been identified within the 33/66 kD
COON-terminal fragment of fibronectin, named the `CS1'
peptide (32-34), the 'FN-C/H I' peptide (35, 36) and the
'FN-C/H IF peptide (35, 36) (Fig. 1). The x4(31 integrin
complex acts as the receptor for the CS1 region (33, 34), while
cell surface heparin-like molecules are implicated in mediating
cell adhesion to the FN-C/H I and FN-C/H II cell adhesion
sites (35, 36).
We have recently demonstrated that very primitive bone
marrow derived hematopoietic progenitors with long-term
in vitro repopulating capacity (long term bone marrow cul-
ture initiating cells [LTBMC-IC]) demonstrate significantly
greater capacity of adhering to irradiated allogeneic stromal
layers than more differentiated clonogenic progenitor cells
(5). In the present study, we demonstrate that primitive
LTBMC-IC, multilineage CFU-MIX progenitors and single
lineage BFU-E and CFU-GM adhere to the 33/66kD heparin-
binding cell-adhesion promoting fragment offibronectin. In
contrast, single lineage BFU-E and CFU-GM but neither
primitive LTBMC-IC nor multi-lineage CFU-MIX adhere
to the 75 kD RGDS-dependent cell-binding fragment of
fibronectin. We demonstrate that the three adjacent cell-
attachment sites in the 33/66 kD RGDS-independent cell-
adhesion promoting fragment of fibronectin are important
in the adhesion of hematopoietic progenitors to this frag-
t Abbreviations used in this paper. LTBMC-IC, long term bone marrow
culture initiating cells; RGDS, arginyl-glyryl-aspartyl-serine.
ment of the fibronectin molecule. Furthermore, differentia-
tion from primitive LTBMC-IC and multi-lineage CFU-MIX
progenitors to more differentiated single lineage BFU-E and
CFU-GM progenitors is associatedwith changes in cell adhe-
sion to the three RGDS-independent cell-attachment sites in
the COOH-terminal cell-adhesion promoting fragment. These
studies suggest that maturation and differentiation of hema-
topoietic elements is accompanied by acquisition of new func-
tional cell surface receptors which may allow progenitor cells
to migrate to distinct loci in thebone marrow microenviron-
ment. Finally, adhesion of LTBMC-IC to intact allogeneic
irradiated stroma can in part be blocked by FN-C/H II alone,
while adhesion can be blocked to a greater extent by a com-
bination of peptides FN-C/H I, FN-C/H II, and CS1. These
findings indicate that receptors present on primitive LTBMC-
IC responsible for their adhesion to these cell attachment sites
maybe important for homing ofprimitive hematopoietic pro-
genitors to the bone marrow microenvironment and in their
close interaction with elements of the bone marrow stroma.
Materials and Methods
Marrow Samples.
￿
Bone marrow samples were obtained from
normal healthy volunteers after informed consent was obtained using
guidelinesapproved by the Committee on the Use of Human Sub-
jects at the University of Minnesota. Heparinized bone marrow
samples were obtained by aspirationfrom the posterior iliac crest.
Bone marrow mononuclear cells (BMMNC) were isolatedby Ficoll-
Hypaque (Sigma Diagnostics, St. Louis, MO) density gradient cen-
trifugation (sp. grav. 1.077) for 30' at 37°C and 400 g.
Selection ofPurified Progenitor Populations
BMMNC were enriched for primitive hematopoietic progen-
itors by an immunomagnetic depletion ofcommitted myeloid cells,
monocytes, and lymphoid precursors. Further separation was ac-
complished by a positive FACS selection for cells with low/very
low horizontaland low vertical light scatter properties and according
to CD34 and HLA-DR antigen expression.
Immunomagnetic depletion was performed as published (5):
BMMNC were incubated for 30' at 4°C with a mixture of 50
ng/106 cells mAbs with overlapping specificity for T and B lym-
phocytes, NK cells, monocyte and myeloid lineage including anti-
CD2 (leu 5), anti-CD3 (leu 4), anti-CD16 (leu 11), anti-CD11(leu
15), anti-CD15 (MY18), anti-CD19 (leu 12), anti-CD56 (leu 19),
and anti-CD71 (transferrin) (Becton-Dickinson and Co., Moun-
tain View, CA), washed twice and incubated with immunomag-
netic beads coated with goat anti-mouse IgG and IgM (Advanced
Magnetics Inc., Cambridge,MA) for 30' at 4°C with periodic agi-
tation (30-40 x 106 beads were used per 106 cells). Rosettes and
free particles were removed using a BioMag Separator (Advanced
Magnetics Inc.). The rosette-free fraction was called lineage nega-
tive BMMNC.
FACS Sort.
￿
Lineage negative cells obtained from immunomag-
netic separation were first incubated with 100 hg goat F(ab)'2
anti-mouse IgG (Tago Inc.) to block any mouse IgG mAb still
present after immunomagnetic depletion. The cells were next in-
cubated with 500 pig mouse IgG (Sigma Diagnostics) to block any
unbound active site on the goat F(ab)'2 anti-mouse IgG. Cellswere
incubated with 0.25 Rg of anti-CD34 antibody/106 cells (HPCA-
1) (Becton Dickinson) for 30' at 4°C and washed twice. We then
treated the cells with 0.25 Wg/106 cells fluorescein conjugated goat
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Cellswere then incubated with 500 lAg mouse IgG (Sigma Chem-
icalCo .), followed by a 30' incubation with0.25,ug of anti-HLA-
DR-PE antibody/106 cells (L234) (Becton-Dickinson and Co.) .
After washing, cellswere sorted on aFRCS-Star laser flow cytom-
etry system (Becton-Dickinson and Co .) equipped with a consort
40 computer. A first selection consisted ofgating in for cells with
low vertical and very low/low horizontal light scatter properties .
Thesorting gates were then set to isolate cells expressing high den-
sity CD34 antigen and either absence (referred to as DR- cells)
or presence (referred to as DR` cells) of HLA-DR antigens.
Short Term Methykellulose Assay.
￿
Cells recovered in the adherent
fraction of adhesion assays performed with DR* cells were plated
in methylcellulose (final concentration 1.12%) (Fisher Scientific,
Fair Lawn, NY) with IMDM (Gibco Laboratories, Grand Island,
NY) supplemented with30% FCS(HyClone Laboratories, Logan,
UT), antibiotics (penicillin 1,000U/m and streptomycin 100U/ml ;
Gibco Laboratories), 5 x 10- sM 2-ME, 3 IU recombinant ery-
thropoietin (Epoetin) (Amgen, Thousand Oaks, CA)and10% con-
ditioned media from the bladder carcinoma cell line 5637 . Cul-
tureswere incubated in ahumidified atmosphere at 37°C and 5%
COZ for 18-21 d . The cultures were assessed at day 18-21 ofcul-
ture for the presence ofCFU-MIX, CFU-GM and BFU-E as pre-
viously described (5) . Likewise, cells harvested at week 5 from
LTBMC initiated with DR - cells were plated in short term
methylcellulose culture and secondary CFU-MIX, CFU-GM and
BFU-E were enumerated at day 14-16 of culture.
LongTerm Bone Marrow Cultures (LTBMC).
￿
Bone marrow de-
rived stromal cell cultures were prepared as described (5) . DR-
(10°/well) cells were then plated or panned (5) on allogeneic ir-
radiated stroma in 0.5 ml ofLTBMC media (IMDM with 12.5%
FCS, 12.5% horse serum [HyClone Laboratories], 2 MM L-glu-
tamine, penicillin 1,000 U/mand streptomycin 100 U/ml and 10-6
M hydrocortisone [A-Hydrocort] [Abbott Laboratories, North
Chicago, IL]) . Cells recovered in adherent fractions from adhesion
assays initiated with DR - cells were also plated in LTBMC for
5 wk . All LTBMC cultures were maintained in a humidified at-
mosphere at 37°C and 5% COz. At weekly intervals the cultures
were fedby removing half ofthe supernatant and replacing it with
fresh media. At 5 wk of culture, nonadherent cells present in the
overlying supernatant andadherent cells recovered from the stromal
layers after treatment with 0.1% collagenase were assayed for the
presence of clonogenic progenitors in short term methylcellulose
assay .
It is believed that committed progenitor cells present in the ini-
tial bone marrowpopulation fail to produce clonogenic progenitor
growth in LTBMC4-5 wk after initiation of such cultures (5-8) .
The number of clonogenic progenitors recovered from both ad-
herent and nonadherent layers ofLTBMC at 5 wk ofculture may
therefore represent progeny of more primitive progenitors which
can sustain long term in vitro hematopoiesis and are termed LTBMC
initiator or LTBMC-IC (5-8) .
Purification of Fibronectin and Fibronectin Fragments.
￿
Human
plasma fibronectin was purified as a by-product of Factor VIII
production by sequential ion exchange and gelatin chromatography
(31) . A 75 kD tryptic fragment containing the cell binding frag-
ment RGDS was purified from long-term (90') tryptic digestion
as previously described (31) . The 33kD and66kD COOH-terminal
heparin binding fragments were purified from short term (15')
tryptic/catheptic digest ofintact fibronectin by sequential heparin
and antibody column chromatography as described (31) . The pu-
rity of intact fibronectin, the 33/66 kD fragment and the 75 kD
fragment offibronectin was verified bySDS-PAGE andCoomassie
brilliant blue staining.
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Peptide Synthesis and Characterization.
￿
Peptides from fibronectin
were synthesized at the Microchemical Facility of the University
ofMinnesotaby Dr. Robert Wohlheuter using a peptide synthesizer
(System990;Beckman InstrumentsCo., Fullerton, CA).The proce-
dures used were based on the Merrifield solid-phase system as de-
scribed previously (37) . Lyophilized crude peptides were purified
by preparative reverse-phase HPLC on a C-18 column, using an
elution gradient of 0-60% acetonitrile with 0.1% trifluoroacetic
acid in water. The purity and composition of the peptides was
verified byHPLC analysis ofhydrolysates prepared by treating the
peptides under nitrogen in 6NHCl overnight at 110°C. Thepep-
tides include heparin binding peptide I, FN-C/H I, and heparin-
binding peptide II, FN-C/H II which have the sequencesYEK
PGSPPREVVPRPRPGV (35,36) andKNNQKSEPLIGRTKKT
(35, 36) respectively and peptide CS1, which has the sequence
DELPQLVTLPHPNLHPGEILDVPST (32-34) (Fig. 1) . The se-
quences use the single amino acid code (K = lysine,R = arginine,
H=histidine, E=glutamic acid, D=aspartic acid,Q = glutamine,
N = asparagine, P = proline, G = glycine, S = serine, T = threo-
nine, V = valine, I = Isoleucine, L = leucine, Y = tyrosine) .
Conjugation ofthe Peptides to Oualbumin.
￿
The synthetic peptides
were chemically conjugated to ovalbumin with 1-ethyl-3(3-
dimethylaminopropyl)-carbodiimide hydrochloride (EDC) (Sigma
Chemical Co .) as described (35, 36) . Briefly, equal amounts (by
weight) ofthe peptides and ovalbumin are solubilized in waterand
mixedwith a 10-fold excess (by weight) ofEDC dissolved in water.
The samples were mixed overnight at 4°C on a circular rotator.
The coupled peptides were dialyzed extensively in PBS to remove
excess EDC (Spectrapore 6, 10 kD exclusion; Spectrum Medical
Industries, Los Angeles, CA). Themolar ratio of each of the pep-
tides to BSA was 1:12 for peptide CS1, 1:4 for FN-C/H I and 1:5
for FN-C/H II . The conjugates were stored at -20°C until use .
Generation and Purification ofPolyclonal Antibodies Against Synthetic
Peptides. Polyclonal antibodies were generated against the different
synthetic peptides coupled to keyhole limpet hemocyanin (KLH ;
SigmaChemicalCo.) using carbodiimide as a couplingreagent (35,
36, 39-40) . After the coupling reaction, the coupled peptide was
dialyzed in Spectrapore 6tubing (SpectrumMedical Industries) with
an 1,000-D exclusion so that only the excess carbodiimide was re-
moved andanyuncoupled peptide will remain in the tubing. This
mixture was then concentrated in Acquacide II (Calbiochem-
BehringCorp., LaJolla, CA) to a final concentrationof10 mg/ml,
and aliquots were stored at -70°C . The coupling of the peptide
was verified by the use of radioiodinated peptide in a parallel reaction.
Thecoupled mixturewas then used to immunizeNewZealand
White Rabbits . Immunization was performed by mixing an equal
volume of peptide/KLH conjugate with CFA and injecting this
mixture into multiple sites of the shaved back of the rabbits
(2 mg of the conjugate/rabbit) . Subsequently biweekly boosts in
incomplete Freund's adjuvant were injected intra muscular into the
hind legs ofrabbits. Sera were collected 7-10dafter the sixthim-
munization, and tested by ELISA for reactivity against theuncou-
pled peptides and various other ligands.
IgGwas purified from pooled immune sera by precipitation with
a final concentration of45% ammonium sulphate overnight at4°C .
This precipitate was pelleted by centrifugation, resolubilized, and
dialyzed against 0.035MNaCl in 0.025M Tris, pH8.2 . The IgG
was purified over aDEAE anion exchange column as described pre-
viously (35, 36) . Purity of the IgG was determined bySDS-PAGE
and Coomassie brilliant blue staining of the gel. Retained im-
munoreactivity of the purified IgG was verified by ELISA .
Cell Adhesion Assays. Substrata were prepared as follows :
fibronectin, proteolytic fragments from fibronectin and synthetic
peptides were diluted to the appropriate concentrations in Voller'scarbonate buffer (31) . Proteins were adsorbed to wells of 48 well
plates (Costar, Cambridge, MA) overnight in a humidified at-
mosphere at 37°C . Nonspecific sites were blocked the following
day with 5 mg/ml BSA (BSA, fatty acid free, Miles, Naperville,
IL) in PBS, pH 7.4, for2-3 h. Control wells were adsorbed with
BSA 5 mg/ml or ovalbumin-coupled ovalbumin and then blocked
with BSA in PBS. DR- cells andDR+ cells were suspended at
4x 104 cells/ml in IMDM + 1% BSA (Sigma Diagnostics) or
LTBMCmediaand250pl cell suspension was plated in ligand coated
or control wells for 3 h at 37'C and 5% C02 . The nonadherent
and loosely attached cells were removed after 3 h by 4-5 consecu-
tive washings with warm IMDM after standardized horizontal
shaking of the plates (30 sec, 100 excursions per min) . Since we
were unable to demonstrate significant differences between the adhe-
sion ofDR - cells or DR' cells diluted in either IMDM/BSA or
LTBMCmedia, results presented are pooled data of adhesion assays
performed either inIMDM/BSA or LTBMC media . Cells present
in the adherent fractions of adhesion assays initiated with DR-
cells were evaluated for the presence ofLTBMC-IC by culturing
inLTBMC for 5 wk and evaluating these cultures for the presence
ofsecondaryclonogenic progenitors . Cells recovered in the adherent
fraction of adhesion assays initiated with DR+ cells were evalu-
ated for the presence of single lineage BFU-E and CFU-GM pro-
genitors and multi-lineageCFU-MIX progenitors by culturing in
short term methyl cellulose culture. Percent adhesion was calcu-
lated as (the number of cells adherent to ligand coated wells -
the number of cells adherent toBSA or OVA/OVAcontrol wells,
divided by the total input cells) x 100 .
Inhibition ofCell Adhesion .
￿
Experiments were designed to
evaluate the specificity of LTBMC-IC, CFU-MIX, BFU-E and
CFU-GM adhesion to the33/66kD heparin-binding cell-adhesion
promoting fragment of fibronectin and to peptide-ovalbumin con-
jugates. In the first type of assay, inhibition of cell adhesion to the
33/66 kD fragment of fibronectin or to ovalbumin-coupled pep-
tides (at concentrations inducing half-maximal adhesion of hema-
topoietic progenitors) was tested by preincubating DR- and DR'
cells with increasing concentrations of free synthetic peptides for
30' before the cell adhesion assays described above . In the second
assay, increasing concentrations of purified polyclonal rabbit IgG
raised against peptides FN-C/H I, FN-C/H II and CS1 (37, 39)
were added to wells which had previously been coated with the
33/66 kD fragment or ovalbumin-coupled peptides (at a concen-
tration inducing half-maximal adhesion of hematopoietic progen-
itors), andincubated for 30' at 37°C before the cell adhesion assays .
In both above described competition assays, the exogenous pep-
tides and polyclonal IgG remain in the wells for the duration of
the cell adhesion assay. Inhibition ofadhesion by different synthetic
peptides or antibodies was then calculated as 100 - [(number of
cells adherent in the treated population/numberof cells adherent
in the untreated population) x 1001 .
Statistical Analysis.
￿
Results ofexperimental points obtained from
multiple experiments were reported as thex f 1SEM. Significance
levels were determined by two-sided students t-test analysis .
Results
Primitive Multi-lineage Progenitors but not Single-lineage He-
matopoietic Progenitors Fail to Adhere to the RGDS-containing
75 kD Cell-binding Fragment of Fibronectin . We first evalu-
ated the adhesive interactions of specific hematopoietic pro-
genitor cells with fibronectinby performing adhesion assays
to wells coated with increasing concentrations of fibronec-
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Figure 1 .
￿
Structure of fibronectin. Location of the 75 kD RGDS-
dependent cell-binding fragment, the 33/66 kD majorCOOH-terminal
heparin-binding cell-adhesion promoting fragment and synthetic peptides,
FN-C/H I, FN-C/H II and CS1, within the intact fibronectin molecule .
Also depicted is the IIIcs region found only in the A-isoform of human
plasma fibronectin .
tin and its proteolytic fragments . Adherent fractions were
then cultured in LTBMC culture (DR- cells) or in short-
term methylcellulose assay (DR+ cells) and the number of
LTBMC-IC, CFU-MIX, BFU-EorCPU-GM present in the
adherent cell populations was enumerated. Preliminary studies
demonstrated that the 3-h incubation of DR - and DR'
20 40 60 so 100
Fibronectin concentration (pig/ml)
Figure 2 .
￿
104DR- cells (n = 7) and DR" cells (n = 7) were plated
in fibronectin coated or BSA control wells for 3 h at 37'C and 5% C02 .
Adherent cells were cultured inLTBMC culture (DR- cells) or in short-
term methylcellulose assay (DR+ cells) and the number of LTBMC-IC,
CFU-MIX, BFU-E or CFU-GM present enumerated. Percent adhesion
was calculated as (the number of progenitors adherent to ligand coated
wells - the number of progenitors adherent to BSA/the total input pro-
genitors) x 100 . Mean number ofprogenitors present in the starting popu-
lation was : for LTBMC-IC : 374 ± 15/104 cells, forCFU-MIX: 4.66 t
1.7/103 cells, for BFU-E : 17.4 *- 6.7/103 cells, for CFU-GM: 106
49/10 3 cells.cells in ligand coated wells did not significantly decrease their
viability and cloning efficiency (data not shown) .
Adhesion ofprimitive LTBMC-IC, immature CFU-MIX
and single lineage BFU-E and CFU-GM progenitors to in-
tact fibronectin was not significantly different (Fig . 2) . Primi-
tive LTBMC-IC and CFU-MIX adhered to the 33/66 kD
COOH-terminal heparin-binding fragment of fibronectin
(Fig . 3) . However these primitive progenitors adhered
significantly less to the 75 kD RGDS-dependent cell-binding
fragment (p = 0.007 and p = 0.001) (Fig. 3) . In contrast,
adhesion of single lineage BFU-E andCFU-GM progenitors
occurred equally well to both the 75 kD RGDS-dependent
and the 33/66 kD RGDS-independent cell-adhesion fragments
(Fig . 3) . These findings suggest that upon maturation, primi-
tive progenitor cells acquire functional receptors which allow
more differentiated single-lineage progenitors to interact with
fibronectin through both an RGDS-dependent and anRGDS-
independent mechanism .
Adhesion ofHematopoietic Progenitors to the 33/66kD Cell-
adhesion PromotingFragment Can Occur through at Least Three
RGDS-independent Cell-attachment Sites . Three adjacent cell
adhesion promoting sites contained within synthetic peptides
FN-C/H I, FN-C/H II, and CS1, have been described in
the cell adhesion promoting heparin-binding fragment of
fibronectin. In a second set of experiments we established
the role of these three sites in the adhesion ofhematopoietic
progenitors . Although all experiments were performed for
LTBMC-IC, CFU-MIX, BFU-E, andCFU-GM, we elected
for the sake of simplicity to present only specific data on adhe-
sion of the CFU-GM progenitors. As can be seen in Fig. 4,
Figure 3 .
￿
104,DR- cells (n - 7) andDR' cells (n - 7) were plated
in ligand coated wells or BSA control wells for 3 h at 37°C and5% C02 .
Adherent cells were cultured in LTBMC culture (DR- cells) or in short-
term methylcellulose assay (DR* cells) and the number of LTBMC-IC,
CFU-MIX, BFU-E orCFU-GM present enumerated . Percent adhesion
was calculated as (the number of progenitors adherent to ligand coated
wells - the number of progenitors adherent to BSA control wells/the
total input progenitors) x 100 . Mean number of progenitors present in
the starting population was : for LTBMC-IC : 374 ± 15/10° cells, for
CPU-MIX : 4.66 ± 1.7/103 cells, for BFU-E : 17.4 ± 6.7/103 cells, for
CPU-GM : 106 t 49/103 cells.
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Figure 4 .
￿
104 DR' cells (n = 7) were plated in wells coated with in-
creasing concentrations of OVA-coupled FN-C/H I, FN-C/H II or CS1
peptides or OVA-OVA coated control wells for 3 h at 37°C and 5% C02 .
Adherent cells were cultured in short-term methylcellulose assay and the
number ofCPU-GM present enumerated . Percent adhesion was calculated
as (the numberof progenitors adherent toligand coated wells - the number
of progenitors adherent to control wells/the total input progenitors)
x 100 . Mean number of progenitors present in the starting population
was 106 ± 49 CFU-GM/103 cells .
purified, immobilized synthetic peptide FN-C/H I, peptide
FN-C/H II and peptide CS1 were equally effective at
promoting adhesion of CFU-GM progenitors .
We then examined the mechanisms through which hema-
topoietic progenitors adhere to peptides FN-C/H I andFN-
C/H II by performing adhesion inhibition experiments with
both free synthetic peptides (Fig . 5) and polyclonal IgG anti-
bodies raised against the peptides (Fig. 6) . In a first set of
experiments FACS sorted hematopoietic progenitor popula-
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Figure 5 .
￿
104 DR* cells were preincubated with increasing concentra-
tions of free synthetic peptides FN-C/H I, FN-C/H II orGRGDSP for
30' before the adhesion experiments . Cells were then allowed to adhere
to substrata coated withOVA coupledpeptide FN-C/H I (A) or FN-C/H
II (B) for an additional 3 h and this in the presence of the free peptides .
Adherent cells were plated in methylcellulose assay and the number ofCFU-
GM present enumerated . Inhibition of adhesion by synthetic peptideswas
calculated as 100 - ([number ofprogenitors adherent in the treatedpopu-
lation/number ofprogenitors adherent in the untreated population] x 100) .
Mean number of progenitors present in the starting population 152 ±
36.8 CFU-GM/103 cells (n = 5) .tions were preincubated with increasing concentrations of
synthetic peptide GRGDSP, the sequence of minimal recog-
nition in the centrally located 75 kD cell-binding fragment
of fibronectin, or with free synthetic peptidesFN-C/H I and
FN-C/H II for 30' before the adhesion experiments . Adhe-
sion ofCFU-GM progenitors to substrata coated withOVA-
coupled peptides FN-C/H I (Fig. 5A) andFN-C/H II (Fig.
5 B) could be inhibited significantly and in a dose dependent
fashion by preincubating cells with increasing concentrations
of free synthetic peptides FN-C/H I or FN-C/H II respec-
tively, but not by free synthetic peptide GRGDSP . We also
evaluated the adhesion of hematopoietic progenitors to sub-
strata coated with OVA coupled peptidesFN-C/H I and FN-
C/H II after preincubating the wells with increasing con-
centrations of normal rabbit IgG, an antibody raised against
an irrelevant synthetic peptide representing a cell adhesion
fragment ofcollagen type IV (anti-IVPI I polyclonal rabbit
IgG antibody) (38) or polyclonal rabbit IgG antibodies raised
against peptides FN-C/H I and FN-C/H II (Fig. 6) . Adhe-
sion ofCFU-GM to substrata coated with OVA-coupled pep-
tides FN-C/H I (Fig . 6 A) and FN-C/H II (Fig . 6 B) was
inhibited significantly and in a dose dependent fashion by
preincubating the wells with polyclonal IgG antibodies raised
against the peptides FN-C/H I andFN-C/H II respectively,
but not by rabbit IgG or anti-IVH I.
We next determined the importance of these three syn-
thetic peptides for the interaction of hematopoietic progen-
itors with the intact 33/66 kD cell-adhesion promoting frag-
ment of fibronectin by performing adhesion inhibition
experiments with free synthetic peptides (Fig. 7 A) or poly-
clonal antibodies raised against these peptides (Fig . 7 B) . Prein-
cubation of FAGS purified hematopoietic progenitors with
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Figure 6 .
￿
Substrata coated with OVA coupled peptide FN-C/H I (A)
or peptide FN-C/H II (B) were preincubated with increasing concentra-
tions of polyclonal IgG rabbit antibodies raised against synthetic peptide
FN-C/H I (A) or peptide C/H II (B), peptide IV-H I or normal rabbit
IgG for 30' before the adhesion experiments: 104 DR* cells were then
allowed to adhere to the preincubated substrata for an additional 3 h and
this in thepresence ofthe antibodies. Adherent cells wereplated in methyl-
cellulose assay and the number ofCPU-GM enumerated . Inhibition of
adhesion by antibodies was calculated as 100 - ([number of progenitors
adherent to the preincubated substrata/number of progenitors adherent
to the untreated substrata] x 100) . Mean number ofprogenitors present
in the starting population was 111.7 ± 16 .7 CFU-GM/103 cells (n = 4) .
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￿
(A) 10 4 DR* cells were preincubated with increasing con-
centrations of tree synthetic peptides FN-C/H I, FN-C/H II, CSl or
GRGDSP for 30' before the adhesion experiments . Cells were then al-
lowed to adhere to substrata coated with the 33/66 kD heparin-binding
cell-adhesion promotingfragment offibronectin for an additional 3 h and
this in the presence of the free peptides . (B) Alternatively, wells coated
with the 33/66 kD proteolytic fragment offibronectin were preincubated
for 30' before the adhesion assay with increasing concentrations of poly-
clonal IgG rabbit antibodies raised against synthetic peptide FN-C/H I,
peptide FN-C/H II, peptide CS 1 or rabbit IgG. 104DR* cells were then
allowed to adhere to the preincubated substrata for an additional 3 h and
this in the presence ofthe antibodies . Adherent cells were plated in methyl-
cellulose assay and the number of CFU-GM enumerated. Inhibition of
adhesion was calculated as 100 - ([number of progenitors adherent in
the treated population/number of progenitors adherent in the untreated
population] x 100) . Mean number of progenitors present in the starting
population was 106 ± 49 CFU-GM/103 cells (n = 5) (A) and 111 .7 ±
16 .7 CFU-GM/103 cells (n = 5) (B) .
free synthetic peptides FN-C/H I, FN-C/H II and CS1, but
not peptide GRGDSP, prevented the adhesion ofCFU-GM
progenitors to the 33/66 kD cell-adhesion promoting frag-
ment in a dose dependent fashion. Similarly, preincubatinn
of wells coated with the 33/66kD cell-adhesion promoting
fragment with polyclonal antibodies raised against peptides
FN/CH-I, FN-C/H II and CSl inhibited significantly the
adhesion ofCFU-GM progenitors to the heparin-binding cell
attachment fragment, while such inhibition was not seen with
normal rabbit IgG (Fig. 7 B) .
These studies confirm that, as for other cell types, all three
synthetic adhesion-promoting sites in the heparin-binding
cell-adhesion promoting fragment of fibronectin are effec-
tive at promoting adhesion ofhuman hematopoietic progen-
itors . Moreover, adhesion of hematopoietic progenitors to the
heparin-binding cell-adhesion promoting fragment of FN
occurs in an RGDS independent fashion.
Adhesion of Primitive, Multilineage Progenitors to the 33/66
kD Cell-adhesion Promoting Heparin-binding Fragment ofFibro-
nectin May Involve IhfferentMechanisms Than That ofMore Com-
mitted Single-lineage Progenitors . We next determined the
mechanism through which the adhesion ofprimitiveLTBMC-
IC, mufti-lineage CFU-MIX progenitors and more committed
single-lineage BFU-E and CFU-GM progenitors adhere to
the 33/66 kD cell-adhesion promoting fragment of fibro-
nectin . We first determined the adhesion of all four cell popu-
lations to FN-C/H I, FN-C/H II and CS1 (Fig. 8) . Primi-
tive LTBMC-IC and immature multilineage CFU-MIXprogenitors adhered significantly better to peptide FN-C/H
II than to peptides FN-C/H I and CS1 (Fig . 8) . In contrast,
single lineage BFU-E and CFU-GM progenitors adhered
equally well to peptideFN-C/H 1, peptide FN-C/H II and
peptide CS1 (Fig. 8) .
We next verified the mechanism underlying the adhesion
of primitive LTBMC-IC, multi-lineageCFU-MIX and single-
lineage BFU-E and CFU-GM to the 33/66 kD heparin-
binding cell-adhesion promoting fragment of FN by per-
forming adhesion inhibition experiments . We first evaluated
the adhesion of all four progenitor populations to the heparin-
binding fragment in the presence of free synthetic peptides
FN-C/H I, FN-C/H II and CS1. As shown in Fig . 9, adhe-
sion of primitive LTBMC-IC and multi-lineage CFU-MIX
progenitors to the 33/66 kD cell-adhesion promoting frag-
ment was inhibited by preincubating FRCS sorted hemato-
poietic progenitors with free synthetic peptide FN-C/H II
(p = 0.02 and p < 0.001, respectively), but less so by pep-
tides FN-C/H I (p = 0.06 and p = 0.08, respectively) and
CS1(p = 0.08 andp = 0.08, respectively) . In contrast, adhe-
sion of single-lineage BFU-E and CFU-GM to the 33/66
kD cell-adhesion promoting fragment could be inhibited
equally well by preincubating the FACS sorted DR' cells
with either free synthetic peptide FN-C/H I (p = 0.01 and
p = 0.05, respectively), peptide FN-C/H II (p = 0.05 and
p = 0.01, respectively) and peptide CS1 (p = 0.02 and p
= 0.01, respectively) before the adhesion assay (Fig . 9). Similar
results were obtained in adhesion inhibition experiments in
which the adhesion of hematopoietic progenitors to substrata
coated with the 33/66 kD cell-adhesion promoting fragment
of fibronectin was inhibited by polyclonal rabbit IgG anti-
Figure 8 .
￿
104 DR - cells (n = 7) andDR+ cells (n = 7) were plated
in ligand coated or OVA-OVA control wells for 3 h at 37°C and 5% C02-
Adherent cells were plated in either LTBMC (DR - cells) or methylcel-
lulose assay (DR* cells) and the number of LTBMC-IC, CFU-MIX,
BFU-E andCFU-GM enumerated . Percent adhesion was calculated as (the
number of cells adherent to ligand coated wells - the number of cells
adherent to controlwells/the total input progenitors) x 100 . Mean numbers
of progenitors present in the starting population was : for LTBMC-IC :
374 ± 15/10 4 cells, for CFU-MIX : 4.66 ± 1.7/103 cells, for BFU-E : 17 .4
± 6.7/103 cells, for CFU-GM : 106 ± 49/103 cells.
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Figure 9 .
￿
10 4DR- (n = 4) andDR* (n = 5) cells were preincubated
with increasing concentrations offree synthetic peptides FN-C/H 1, FN-
C/H II for 30' before the adhesion experiments . Cells were then allowed
to adhere to substrata coated with the 33/66 kD heparin-binding cell-
adhesion promoting fragment of fibronectin for an additional 3 h and this
in the presence of the free peptides. Adherent cells were plated in either
LTBMC (DR- cells) or methylcellulose assay (DR* cells) and the
number of LTBMC-IC, CFU-MIX, BFU-E and CFU-GM enumerated .
Inhibition of adhesion by synthetic peptides was calculated as 100 -
([number of progenitors adherent in the treated population/number of
progenitors adherent in the untreated population] x 100). Data represent
results obtained at 80 Fog/ml free synthetic peptide blocking concentra-
tion. Mean number ofprogenitors present in the starting population was :
for LTBMC-IC: 424 ± 39.4/104 cells, for CFU-MIX : 4.66 ± 1.7/103
cells, for BFU-E : 17.4 ± 6.7/10 3 cells and for CFU-GM : 106 ± 49/103
cells.
bodies raised against peptide FN-C/H 1, peptide FN-C/H
II and peptide CS 1 (Fig. 10) .
These studies suggest that the FN-C/H II cell attachment
site has a more dominant role in the adhesion of primitive
LTBMC-IC andCFU-MIX to the 33/66 kD heparin-binding
cell-adhesion promoting fragment while the adjacent cell-
attachment sites FN-C/H I and CS1 may be less important
in this interaction . In contrast, adhesion ofmore differen-
tiated single-lineage BFU-E and CFU-GM to the 33/66 kD
heparin-binding cell-adhesion promoting fragment may in-
volve all three defined cell attachment sites .
Adhesion ofPrimitive LTBMC-IC to Intact Irradiated Stroma
Can Be Inhibited Partially by I+ptideFN-C/H 11andAlmost Com-
pletely by a Combination ofFN-C/H 11 with Peptides FN-C/H
I and CS1 . Finally, we evaluated the ability of peptides
FN-C/H 1, FN-C/H II and CS1 to inhibit the adhesion of
LTBMC-IC to intact allogeneic stroma (Fig. 11) . DR- cells
were incubated for 30' at 37°C in a humidified atmosphere
in the absence or presence of either FN-C/H I, FN-C/H
II orCS1 before panning on irradiated allogeneic stromal layers
(5) . After 2 h, non-adherent cells were removed by extensive
washing withwarm IMDM . Cells adherent to the irradiated
stromal layers were then cultured further in LTBMC . At week
5 of culture, stromal and supernatant fractions were evalu-
ated for the presence of LTBMC-IC as described (5) .
As we have previously demonstrated, virtually all LTBMC-
IC adhere to irradiated stroma when panned for 2 h (94.6
± 14.6% recovery ofLTBMC-IC in LTBMC initiated withFigure 10.
￿
Substrata coated with the 33/66 kD heparin-binding cell-
adhesion promoting fragment of fibronectin were preincubated with in-
creasing concentrations ofpolyclonal IgG rabbit antibodies raised against
synthetic peptides FN-C/H I, FN-C/H II, CS1 or rabbit IgG for 30' be-
fore the adhesion experiments. Purified DR- (n = 4) and DR' (n =
5) populations (104 cells/well) were then allowed to adhere to the prein-
cubated substrata for an additional 3 h and this in the presence ofthe anti-
bodies. Adherent cells were plated in either LTBMC (DR- cells) or
methylcellulose assay (DR' cells) and the number of LTBMC-IC, CPU-
MIX, BFU-E and CPU-GM present enumerated. Inhibition of adhesion
by antibodies was calculated as 100 - ([number of progenitors adherent
to the preincubated substrata/number ofprogenitors adherent to the un-
treated substrata) x 100) . Data represent results obtained at antibody con-
centration of500,ug IgG/ml . Mean number of progenitors present in the
starting population was: for LTBMC-IC : 270 ± 21.8/104 cells, for CFU-
MIX: 4 ± 1.35/103 cells, for BFU-E: 13 .4 ± 5/103 cells, forCFU-GM ;
111.7 ± 16.7/103 cells .
panned DR- cells compared to plated DR - cells) . Prein-
cubation ofDR' cells in the presence ofpeptide GRGDSP
did not significantly alter the adhesion ofLTBMC-IC to ir-
radiated stroma (p = 0.24) . Preincubation of DR - cells in
the presence of either peptide FN-C/H I (p = 0.5) or pep-
tide CS1 (p = 0.2) inhibited the adhesion of LTBMC-IC
to irradiated stroma although this inhibition did not attain
significance. In contrast, preincubation ofDR- cells with
peptide FN-C/H II inhibited significantly the adhesion of
primitiveLTBMC-IC to irradiated stroma (p = 0.002) . This
inhibition was even more pronounced when DR- cells were
preincubated in the presence of all three synthetic peptides
representing different cell-attachment sites in the 33/66 kD
RGDS-independent cell-adhesion promoting fragment of
fibronectin . Addition ofpeptideGRGDSP to thepreincuba-
tion mixture containing peptidesFN-C/H I, FN-C/H II and
CS1 did not change the degree ofinhibition observed in the
presence of the combination ofFN-C/H I, FN-C/H II and
CS1 . These data indicate that cell surface receptors present
on LTBMC-IC important for the adhesion of these primi-
tive progenitors to peptide FN-C/H II and less so to FN-
C/H I andCS1 may play an important role in their adhesion
to the bone marrow microenvironment .
Discussion
In the present paper we extend our earlier studies which
demonstrated that primitive LTBMC-IC present in the
Figure 11 .
￿
DR - cells (n = 3) were incubated for 30' at 37°C in a
humidified atmosphere intheabsence orpresence ofeitherGRGDSP (500
log/ml), FN-C/H I (20014g/ml), FN-C/H II (200 Fog/ml) or CS1 (200
Fog/ml) diluted in 500 Ftl IMDM + 1% BSA either alone or in combina-
tion . Preincubated DR - cells (104 cells/well) were then panned on irradi-
ated allogeneic stromal layers for 2 h . Nonadherent cells were removed
by extensive washing with warmIMDM. Cells adherent to the irradiated
strott al layers were cultured further inLTBMC. At week 5 of LTBMC,
stromal and supernatant fractions were evaluated for thepresence ofLTBMC-
IC . Inhibition of adhesion by different synthetic peptides either alone or
in combination was calculated as 100 - ([number of LTBMC-IC adherent
in the treated population/number ofLTBMC-IC present inLTBMC initi-
ated with plated cells] x 100) . The mean number ofLTBMC-IC present
in LTBMC initiated with plated DR- cells was : 432 ± 51/104 cells .
DR- cell fraction, but not more differentiated clonogenic
progenitors in the DR+ cell fraction of bone marrow, ad-
here avidily to irradiatedhuman bonemarrow derived stromal
layers when panned for 2 h (5) . We define here additional
differences in adhesive characteristics between primitive multi-
lineage hematopoietic progenitors and their more differen-
tiated single-lineage clonogenic counterparts by examining
the interaction of these progenitors with the prototype adhe-
sion molecule fibronectin.
There is evidence that fibronectin serves as an adhesion mol-
ecule for primitive B220' murine pre-B cells with which it
interacts through x1401 and x5/31 integrin receptors (15, 40) .
Similar observations were made for human primitive B cell
progenitors which have the capacity ofadhering to fibronectin
(14) . Similar to whatwe demonstrate for LTBMC-IC present
in theDR- cell fraction of human bone marrow, adhesion
of the most primitive CD34+/CD10' B cell precursors to
bone marrow derived fibroblast layers was significantly greater
than to wells coated with fibronectin, indicating that mul-
tiple molecules present on stromal cells or in the extracel-
lular matrix may be important for the adhesion of primitive
precursors to bone marrow derived stroma .
The murine IIr3 dependent cell line, FDCP-MIX, murine
CFU-S12 and murine repopulating stem cells are capable of
adhering to murine stromal cell lines and isolated fibronectin
molecules (41) . These murine progenitors interact poorly with
intact fibronectin, but bind avidly to the CS1-containing 33kD
heparin-binding fragment of fibronectin. This adhesion can
be inhibited by anti-o 4o1 antibodies. Depletion ofc401 posi-
tive hematopoietic progenitors from murine bone marrow
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BMMNC in lethally irradiated syngeneic animals. Engraft-
ment can also be prevented by preincubation of murine
BMMNC with anti-x4/31 antibodies, suggesting that mu-
rine hematopoietic stem cells may express the c 4a1 integrin
receptor and that this receptor may have a role in `homing'
of stem cells to the bone marrow .
We demonstrate that the adhesion of primitive human he-
matopoietic progenitors to stroma can in part be blocked by
preincubating these progenitors with peptides FN-C/H II
in combination with peptides FN-C/H I and CS1 . This sug-
gests that such progenitors may have functional heparin-like
cell surface receptors that are important, together with inte-
grin receptors, in their interaction with the bone marrow
environment . Several studies suggest that proteoglycans present
in the bone marrow micro-environment play an important
role in proliferation and differentiation of human hemato-
poietic progenitors . Excessive accumulation ofproteoglycans
within hematopoietic organs in vivo inhibits hematopoietis
(42, 43) possibly by preventing normal interactions ofprimi-
tive hematopoietic progenitors with the stromal microenviron-
ment . Cell-surface chondroitin-sulphate proteoglycans have
been detected on primitive multi-potential FDCP-MIX (44)
and more differentiated FDCP-2 (45, 46) murine hemato-
poietic cell lines . Removal ofproteoglycans from stromal layers
and/or hematopoietic progenitors in LTBMC blocks adhe-
sion ofimmature hematopoietic progenitors to stromal layers
(47, 48) suggesting that proteoglycans present on immature
progenitors may play a role in their attachment to stromal
components .
These observations demonstrate the need for further evalu-
ation of the role of cell surface integrin and/or proteoglycan
receptors in the adhesion and interaction ofhuman primitive
LTBMC-IC with their environment . It will be of interest
to examine the possible instructive and permissive role ofadhe-
sion of such primitive hematopoietic progenitors to fibronectin
for proliferation and differentiation events (10, 26) .
The interaction of murine and human erythroid progen-
itors with fibronectin has been extensively studied . Adhesion
of human (10-12) and mouse (9) erythroid progenitors to
fibronectin can in part be inhibited by the tetrapeptideRGDS
(9-12) and antibodies against fibronectin (9, 10, 49) . Adhe-
sion of CFU-E and mature BFU-E to fibronectin can also
be inhibited by antibodies against the c601 integrin receptor
known to interact with the RGDS sequence in the cellbinding
fragment offibronectin (10) . The present study confirms these
findings, but adds significant new information . We demon-
strate that immature human BFU-E can also adhere to the
COOH-terminal major heparin-binding fragment of fibro-
nectin suggesting that these progenitors may express addi-
tional integrin receptors, such as c 4o1 (33, 34) and/or cell
surface heparin-like receptors (35, 36) important in cell-
extracellular matrix and possibly cell-cell interactions in the
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bone marrow microenvironment . Consistent with this hy-
pothesis is the recent observation by Coloumbel et al . (50)
who demonstrated thatCFU-E express both a401 andc6o1
integrin receptors .
Several studies have indicated that human bone marrow
derived CFU-GM progenitors adhere poorly to intact
fibronectin (11, 12) . Although adhesion ofhumanCFU-GM
progenitors to the intact fibronectin molecule is relatively poor,
the present study demonstrates that such progenitors can ad-
here to the isolated 75 kD cell-binding or 33/66 kD cell-
adhesion promoting fragment . These findings indicate that,
in addition to committed BFU-E progenitors, CFU-GM pro-
genitors may express integrin receptors and/or cell surface
proteoglycan receptors capable of interacting with the cell-
binding fragment of fibronectin as well as with the major
COOH-terminal heparin-binding fragment .
In conclusion, we demonstrate that primitive human he-
matopoietic progenitors adhere to the 33/66 kD RGDS-
independent heparin-binding cell-adhesion promoting frag-
ment of fibronectin . Adhesion of the most primitive hema-
topoietic progenitors, the LTBMC-IC, to intact irradiated
stromal layers is, however, significantly greater than the max-
imal level of adhesion observed to the 33/66 kD fragment
of fibronectin . Moreover, adhesion of LTBMC-IC to intact
irradiated stroma can only in part be blocked by preincuba-
tion of purified DR- cells with free peptide FN-C/H II
alone or in combination with the other cell attachment sites
from the 33/66 kD cell-adhesion promoting fragment of
fibronectin . These observations indicate that, adhesion recep-
tors involved in the interaction between LTBMC-IC and the
33/66 kD cell-adhesion promoting fragment of fibronectin
may play an important role in the binding of such primitive
progenitors to the bone marrow microenvironment . How-
ever, adhesion of these primitive progenitors to intact stromal
layers will likely involve additional adhesion mechanisms . In
contrast to primitive LTBMC-IC and multi-lineage CFU-
MIX progenitors, more differentiated BFU-E andCFU-GM
acquire the ability to adhere to an RGDS-dependent 75 kD
cell-binding fragment and to adhere avidly to additional cell-
attachment sites in the RGDS-independent 33/66 kD cell-
adhesion promoting fragment of fibronectin . This indicates
that differentiation and maturation ofhuman hematopoietic
progenitors seems to be accompanied by alterations in cell
surface adhesion receptor expression and/or function . Such
alterations may then allow cells at different stages ofdifferen-
tiation to interact specifically with distinct supportive loci
within the medullary cavity where additional signals for matu-
ration may become available (51) . It will be of interest to
determine whether further differentiation and maturation of
erythroid or myeloid progenitors is accompanied by additional
alterations in the expression and/or activity of adhesion re-
ceptors that will ultimately allow mature blood elements to
leave the bone marrow microenvironment .References
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